Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Concerning Risankizumab & Psoriasis (Psoriasis vulgaris - Nummular psoriasis - Plaque psoriasis), Risankizumab showed superior efficacy to both placebo and ustekinumab in the treatment of moderate-to-severe Psoriasis (Psoriasis vulgaris - Nummular psoriasis - Plaque psoriasis). Treatment-emergent adverse event profiles were similar across treatment groups and there were no unexpected safety findings.
In the clinical phase III trial identified as NCT02694523, it was demonstrated that [Risankizumab](brain://yokm_OjSPEeA24gdOARLuQ/Risa…